Citation: P. Garnero et al., The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone, BONE, 28(5), 2001, pp. 461-464
Citation: E. Gineyts et al., Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation, RHEUMATOLOG, 40(3), 2001, pp. 315-323
Authors:
Vignon, E
Garnero, P
Delmas, P
Avouac, B
Bettica, P
Boers, M
Ehrich, E
MacKillop, N
Rovati, L
Serni, U
Spector, T
Reginster, JY
Citation: E. Vignon et al., Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers, OSTEO CART, 9(4), 2001, pp. 289-293
Authors:
Chabaud, M
Aarvak, T
Garnero, P
Natvig, JB
Miossec, P
Citation: M. Chabaud et al., Potential contribution of IL-17-Producing Th-1 cells to defective repair activity in joint inflammation: Partial correction with Th-2-promoting conditions, CYTOKINE, 13(2), 2001, pp. 113-118
Authors:
Chavassieux, P
Garnero, P
Duboeuf, F
Vergnaud, P
Brunner-Ferber, F
Delmas, PD
Meunier, PJ
Citation: P. Chavassieux et al., Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: A biochemical, histomorphometric, and densitometric study, J BONE MIN, 16(1), 2001, pp. 89-96
Authors:
Mougin, B
Garnero, P
Borel, O
Compagnon, C
Barbalat, V
Marotte, H
Miossec, P
Citation: B. Mougin et al., A routine assay for the direct analysis of HLA-DR-related shared epitope and B27 alleles in chronic inflammatory arthritis, J IMMUNOL M, 256(1-2), 2001, pp. 47-53
Authors:
Szulc, P
Munoz, F
Claustrat, B
Garnero, P
Marchand, F
Duboeuf, F
Delmas, PD
Citation: P. Szulc et al., Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study, J CLIN END, 86(1), 2001, pp. 192-199
Citation: P. Garnero et al., Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis, CLIN CHEM, 47(4), 2001, pp. 694-702
Authors:
Ferrari, SL
Garnero, P
Emond, S
Montgomery, H
Humphries, SE
Greenspan, SL
Citation: Sl. Ferrari et al., A functional polymorphic variant in the interleukin-6 gene prompter associated with low bone resorption in postmenopausal women, ARTH RHEUM, 44(1), 2001, pp. 196-201
Authors:
Garnero, P
Piperno, M
Gineyts, E
Christgau, S
Delmas, PD
Vignon, E
Citation: P. Garnero et al., Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage, ANN RHEUM D, 60(6), 2001, pp. 619-626
Authors:
Delmas, PD
Pornel, B
Felsenberg, D
Stakkestad, JA
Radowicki, S
Garnero, P
Hardy, P
Dain, MP
Petitier, B
Citation: Pd. Delmas et al., Three-year follow-up of the use of transdermal 17 beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women, AM J OBST G, 184(2), 2001, pp. 32-40
Authors:
Chapurlat, RD
Garnero, P
Breart, G
Meunier, PJ
Delmas, PD
Citation: Rd. Chapurlat et al., Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: The EPIDOS study, BONE, 27(2), 2000, pp. 283-286
Authors:
Duboeuf, F
Sornay-Rendu, E
Garnero, P
Bourgeaud-Lightot, A
Delmas, PD
Citation: F. Duboeuf et al., Cross-sectional and longitudinal assessment of pre- and postmenopausal bone loss with a portable forearm X-ray device: The Ofely study, BONE, 26(2), 2000, pp. 131-135
Authors:
Chabaud, M
Garnero, P
Dayer, JM
Guerne, PA
Fossiez, F
Miossec, P
Citation: M. Chabaud et al., Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis, CYTOKINE, 12(7), 2000, pp. 1092-1099
Authors:
Chapurlat, RD
Garnero, P
Sornay-Rendu, E
Arlot, ME
Claustrat, B
Delmas, PD
Citation: Rd. Chapurlat et al., Longitudinal study of bone loss in pre- and perimenopausal women: Evidencefor bone loss in perimenopausal women, OSTEOPOR IN, 11(6), 2000, pp. 493-498
Authors:
Delmas, PD
Confavreux, E
Garnero, P
Fardellone, P
de Vernejoul, MC
Cormier, C
Arce, JC
Citation: Pd. Delmas et al., A combination of low doses of 17 beta-estradiol and norethisterone acetateprevents bone loss and normalizes bone turnover in postmenopausal women, OSTEOPOR IN, 11(2), 2000, pp. 177-187
Authors:
Chapurlat, RD
Garnero, P
Breart, G
Meunier, PJ
Delmas, PD
Citation: Rd. Chapurlat et al., Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: The EPIDOS study, J BONE MIN, 15(9), 2000, pp. 1835-1841
Authors:
Garnero, P
Sornay-Rendu, E
Claustrat, B
Delmas, PD
Citation: P. Garnero et al., Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study, J BONE MIN, 15(8), 2000, pp. 1526-1536
Authors:
Gineyts, E
Cloos, PAC
Borel, O
Grimaud, L
Delmas, PD
Garnero, P
Citation: E. Gineyts et al., Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover, BIOCHEM J, 345, 2000, pp. 481-485